Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Urbanization in sub-saharan Africa and implication for malaria control.
|
Am J Trop Med Hyg
|
2004
|
5.07
|
2
|
A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.
|
J Infect Dis
|
2002
|
4.14
|
3
|
Exploring the contributions of bed nets, cattle, insecticides and excitorepellency to malaria control: a deterministic model of mosquito host-seeking behaviour and mortality.
|
Trans R Soc Trop Med Hyg
|
2007
|
3.01
|
4
|
Impact of promoting longer-lasting insecticide treatment of bed nets upon malaria transmission in a rural Tanzanian setting with pre-existing high coverage of untreated nets.
|
Malar J
|
2010
|
2.63
|
5
|
Quantifying behavioural interactions between humans and mosquitoes: evaluating the protective efficacy of insecticidal nets against malaria transmission in rural Tanzania.
|
BMC Infect Dis
|
2006
|
2.60
|
6
|
Rapid urban malaria appraisal (RUMA) in sub-Saharan Africa.
|
Malar J
|
2005
|
2.09
|
7
|
Rapid urban malaria appraisal (RUMA) I: epidemiology of urban malaria in Ouagadougou.
|
Malar J
|
2005
|
1.77
|
8
|
High sensitivity detection of Plasmodium species reveals positive correlations between infections of different species, shifts in age distribution and reduced local variation in Papua New Guinea.
|
Malar J
|
2009
|
1.62
|
9
|
Solar drinking water disinfection (SODIS) to reduce childhood diarrhoea in rural Bolivia: a cluster-randomized, controlled trial.
|
PLoS Med
|
2009
|
1.57
|
10
|
Multiplicity and diversity of Plasmodium vivax infections in a highly endemic region in Papua New Guinea.
|
PLoS Negl Trop Dis
|
2011
|
1.47
|
11
|
Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children.
|
Vaccine
|
2003
|
1.39
|
12
|
What should vaccine developers ask? Simulation of the effectiveness of malaria vaccines.
|
PLoS One
|
2008
|
1.38
|
13
|
Force of infection is key to understanding the epidemiology of Plasmodium falciparum malaria in Papua New Guinean children.
|
Proc Natl Acad Sci U S A
|
2012
|
1.33
|
14
|
Rapid Urban Malaria Appraisal (RUMA) III: epidemiology of urban malaria in the municipality of Yopougon (Abidjan).
|
Malar J
|
2006
|
1.24
|
15
|
Rapid Urban Malaria Appraisal (RUMA) IV: epidemiology of urban malaria in Cotonou (Benin).
|
Malar J
|
2006
|
1.24
|
16
|
How much remains undetected? Probability of molecular detection of human Plasmodia in the field.
|
PLoS One
|
2011
|
1.23
|
17
|
MalHaploFreq: a computer programme for estimating malaria haplotype frequencies from blood samples.
|
Malar J
|
2008
|
1.23
|
18
|
Importance of factors determining the effective lifetime of a mass, long-lasting, insecticidal net distribution: a sensitivity analysis.
|
Malar J
|
2012
|
1.21
|
19
|
Predicting the cost-effectiveness of introducing a pre-erythrocytic malaria vaccine into the expanded program on immunization in Tanzania.
|
Am J Trop Med Hyg
|
2006
|
1.16
|
20
|
Simulation of the cost-effectiveness of malaria vaccines.
|
Malar J
|
2009
|
1.13
|
21
|
The dynamics of natural Plasmodium falciparum infections.
|
PLoS One
|
2012
|
1.10
|
22
|
Three different Plasmodium species show similar patterns of clinical tolerance of malaria infection.
|
Malar J
|
2009
|
1.09
|
23
|
Spatial distribution of the chromosomal forms of anopheles gambiae in Mali.
|
Malar J
|
2008
|
1.06
|
24
|
Simulation of malaria epidemiology and control in the highlands of Western Kenya.
|
Malar J
|
2012
|
1.06
|
25
|
Modelling the cost-effectiveness of mass screening and treatment for reducing Plasmodium falciparum malaria burden.
|
Malar J
|
2013
|
1.05
|
26
|
Cost-effectiveness of the introduction of a pre-erythrocytic malaria vaccine into the expanded program on immunization in sub-Saharan Africa: analysis of uncertainties using a stochastic individual-based simulation model of Plasmodium falciparum malaria.
|
Value Health
|
2011
|
1.03
|
27
|
Quantifying the evolution and impact of antimalarial drug resistance: drug use, spread of resistance, and drug failure over a 12-year period in Papua New Guinea.
|
J Infect Dis
|
2010
|
1.00
|
28
|
The usefulness of twenty-four molecular markers in predicting treatment outcome with combination therapy of amodiaquine plus sulphadoxine-pyrimethamine against falciparum malaria in Papua New Guinea.
|
Malar J
|
2008
|
0.98
|
29
|
Selection of mosquito life-histories: a hidden weapon against malaria?
|
Malar J
|
2012
|
0.93
|
30
|
In vivo and in vitro sensitivity of Fasciola hepatica to triclabendazole combined with artesunate, artemether, or OZ78.
|
Antimicrob Agents Chemother
|
2010
|
0.91
|
31
|
Plasmodium falciparum resistance to anti-malarial drugs in Papua New Guinea: evaluation of a community-based approach for the molecular monitoring of resistance.
|
Malar J
|
2010
|
0.91
|
32
|
Measurement of overall insecticidal effects in experimental hut trials.
|
Parasit Vectors
|
2012
|
0.90
|
33
|
Mathematical illiteracy impedes progress in biology.
|
Proc Natl Acad Sci U S A
|
2012
|
0.89
|
34
|
Malaria--a major health problem within an oil palm plantation around Popondetta, Papua New Guinea.
|
Malar J
|
2009
|
0.88
|
35
|
A novel approach for measuring the burden of uncomplicated Plasmodium falciparum malaria: application to data from Zambia.
|
PLoS One
|
2013
|
0.87
|
36
|
Simulated impact of RTS,S/AS01 vaccination programs in the context of changing malaria transmission.
|
PLoS One
|
2012
|
0.87
|
37
|
Micro-encapsulated pirimiphos-methyl shows high insecticidal efficacy and long residual activity against pyrethroid-resistant malaria vectors in central Côte d'Ivoire.
|
Malar J
|
2014
|
0.85
|
38
|
Estimating malaria transmission through mathematical models.
|
Trends Parasitol
|
2013
|
0.84
|
39
|
Relationship between child survival and malaria transmission: an analysis of the malaria transmission intensity and mortality burden across Africa (MTIMBA) project data in Rufiji demographic surveillance system, Tanzania.
|
Malar J
|
2014
|
0.84
|
40
|
Artemisinin-based combination therapy does not measurably reduce human infectiousness to vectors in a setting of intense malaria transmission.
|
Malar J
|
2012
|
0.83
|
41
|
Implementing new health interventions in developing countries: why do we lose a decade or more?
|
BMC Public Health
|
2012
|
0.81
|
42
|
Combination chemotherapy against Clonorchis sinensis: experiments with artemether, artesunate, OZ78, praziquantel, and tribendimidine in a rat model.
|
Antimicrob Agents Chemother
|
2009
|
0.80
|
43
|
Reporting diarrhoea through a vernacular term in Quechua-speaking settings of rural Bolivia.
|
J Health Popul Nutr
|
2011
|
0.75
|
44
|
What every healthcare facility should do now to reduce the potential for workplace violence.
|
J Healthc Prot Manage
|
2016
|
0.75
|
45
|
The IHSSF 2011 Prisoner Escape Study.
|
J Healthc Prot Manage
|
2011
|
0.75
|
46
|
Design of the ROBIN system: whole-arm multi-model sensorimotor environment for the Rehabilitation Of Brain INjuries while sitting or standing.
|
IEEE Int Conf Rehabil Robot
|
2011
|
0.75
|
47
|
Security leadership in a changing healthcare world.
|
J Healthc Prot Manage
|
2014
|
0.75
|